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Abstract
Our objective was to determine the efficacy and feasibility of a new approach for identifying
candidate biomarkers for knee osteoarthritis (OA), based on selecting promising candidates
from a range of high-frequency acoustic emission (AE) measurements generated during
weight-bearing knee movement. Candidate AE biomarkers identified by this approach could
then be validated in larger studies for use in future clinical trials and stratified medicine applica-
tions for this common health condition. A population cohort of participants with knee pain and a
Kellgren-Lawrence (KL) score between 1-4 were recruited from local NHS primary and sec-
ondary care sites. Focusing on participants’ self-identified worse knee, and using our estab-
lished movement protocol, sources of variation in AE measurement and associations of AE
markers with other markers were explored. Using this approach we identified 4 initial candidate
AE biomarkers, of which “number of hits” showed the best reproducibility, in terms of within-
session, day to day, week to week, between-practitioner, and between-machine variation, at
2 different machine upper frequency settings. “Number of hits” was higher in knees with KL
scores of 2 than in KL1, and also showed significant associations with pain in the contralateral
knee, and with body weight. “Hits” occurred predominantly in 2 of 4 defined movement quad-
rants. The protocol was feasible and acceptable to all participants and professionals involved.
This study demonstrates how AE measurement during simple sit-stand-sit movements can be
used to generate novel candidate knee OA biomarkers. AE measurements probably reflect a
composite of structural changes and joint loading factors. Refinement of the method and
increasing understanding of factors contributing to AE will enable this approach to be used to
generate further candidate biomarkers for validation and potential use in clinical trials.
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Introduction
Knee osteoarthritis (OA) is a common degenerative joint condition, particularly amongst
older people. The diagnosis of knee OA relies on X-radiology and involves a combination of
structural features and pain symptoms [1]. However, X-ray features correlate poorly with pain
symptoms and are not useful in diagnosing early knee OA [2]. Whereas the research and man-
agement of other health conditions has been advanced by identification of biomarkers [3] the
paucity of biomarkers limits the potential for clinical trials to evaluate new treatments for knee
OA. Furthermore, the paucity of biomarkers limits the extent to which principles of stratified
medicine might be applied to knee OA, particularly given the clinical and biological heteroge-
neity of this condition. However, the recent development of techniques to measure high-fre-
quency acoustic emission (AE) from knees now offers the possibility of identifying AE features
which reflect the integrity of interactions between joint components during weight bearing
movement [4–9]. Such features would be regarded as "biomarkers" in the sense adopted by the
NIH/FDA BEST resource [3], where molecular, histologic, radiographic, or physiologic char-
acteristics (including, potentially, AE signatures) are types of biomarker. This approach has
face validity with a clear rationale for enabling the identification and development of new knee
OA biomarkers.
AE-based techniques are well established in non-destructive testing and condition monitor-
ing of engineering structures, enabling early detection of damage and defects. By analogy,
smooth and well-lubricated surfaces move quietly against each other, whereas uneven move-
ments of rough, poorly-lubricated surfaces generate acoustic signals.
Exploration of the use of AE in health and medical applications is as yet at an early stage,
and the origins of acoustic signals in joints and other body structures is as yet unknown. How-
ever, knee OA is known to involve damage and defects in cartilage and bone, and by analogy
the impact of these changes on the articulation and dynamics of moving joint surfaces under
weight bearing conditions is likely to be a major basis for generating the acoustic signals cap-
tured by this method. The fact that damage to cartilage and bone are prominent structural fea-
tures of knee OA, and that these features may worsen over time, provides us with a rationale
for investigating the use of AE-based biomarkers, since in principle these would reflect directly
the key pathological feature of this condition.
Previously we have developed a non-invasive, portable system and a standard protocol for
measuring high-frequency AE in knees during weight-bearing movement to identify differ-
ences in AE from healthy and OA knees in different age groups [4–9]. We are now exploring
whether AE may have applications in clinical trials for people previously-diagnosed with knee
OA.
The aim of this study was to determine whether AE measurements from knees of people
with previously-diagnosed knee OA can be used to identify novel candidate biomarkers.
Potentially, any AE candidate biomarkers identified using this approach could then be vali-
dated in larger studies for use in future clinical trials and stratified medicine applications
for this common health condition. Using a population cohort approach we focused on two
key issues, both of which reflect fundamentally important criteria for potential new bio-
markers for knee OA. Firstly, are AE measurements capable of distinguishing between dif-
ferent grades of knee OA severity, and secondly are AE measurements sufficiently
reproducible to have potential utility as biomarkers? Our results show that AE measure-
ments have clear potential to fulfil both these criteria and demonstrate the feasibility of
identifying new candidate biomarkers for knee OA, based on AE measurements, by devel-
oping further this novel approach.
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Methods
Study design
89 adults with X-ray Kellgren-Lawrence (KL) scores of 1 or higher were recruited from NHS
primary and secondary care sites across Lancashire and South Cumbria. People with significant
co-morbidity or previous knee surgery were excluded. All participants were invited to local GP
or hospital clinics for AE measurement and clinical assessment, either for 1 day or for repeated
measurements on 3 consecutive days and 3 consecutive weeks. For those who consented to
repeated measurements (n = 45), each participant underwent AE measurement by each of 3 dif-
ferent AE-trained NHS research practitioners (RPs) on day 1. After completing AE measure-
ment, the sensor was removed, then re-attached by the next RP. Measurements on subsequent
days were made by the same RP. All measurements were taken in NHS clinic environments. All
participants undertook only normal daily weight-bearing activities prior to measurements.
Joint angle and acoustic emissions were simultaneously recorded from both knees using a
‘Joint Acoustic Analysis System’ (JAAS), comprising an AE sensor and electro-goniometer
connected to a computer. Electro-goniometers were positioned laterally to each knee, along
the plane between greater trochanter and lateral malleolus. AE measurements were made
simultaneously on the worse knee (as identified by the participant, and for which an X-ray had
been taken within the previous 4 weeks) and the other knee, using one of 3 JAAS machines.
Radiographs were acquired during standard care at participating NHS Trusts and analysed
centrally. KL scores for the worst knee were assessed and agreed independently by 2 experi-
enced musculoskeletal radiologists.
Acoustic emission
Wide-band AE S9204 sensors (Mistras Group Ltd), with a high sensitivity in the range of
50kHz– 200kHz recorded bursts of acoustic energy generated by stress and friction between
joint components during weight-bearing movement. AE data acquisition operates in event-
based recording mode, such that signals must have significant amplitude to be recorded as an
AE “hit”. Sensors were positioned on both knees anterior to the medial patella retinaculum, and
a thin covering of vaseline applied to ensure good acoustic coupling. Based on previous work,
machine threshold setting for data acquisition was 36 dB, with respect to the 1 μV level, using a
frequency range of 20 to 400 kHz and 5 MSPS sample rate. Data from a concurrent study involv-
ing 73 other participants, with data collected by the same RPs using the same protocol but with
machines calibrated at 20 to 80 kHz, and using a 1 MSPS sample rate to enable recording of lon-
ger waveforms, were used to support interpretation of reproducibility and KL correlation data.
AE data collection
RPs received detailed training in equipment and data collection protocols, and were supported
closely by the study team to ensure standardized protocol use. AE and joint angle were
recorded simultaneously from both knees whilst participants performed sit-stand-sit move-
ments, starting in a seated position with their back against the chair and knees bent at 90
degrees. Each test involved 2 sets of 5 sit-stand-sit movements, following an initial practice of 5
movements with sensors attached. Participants were asked to perform movements as smoothly
as possible at a speed comfortable for them.
Clinical data collection
RPs collected demographic and clinical data at the first assessment, including age, sex, BMI,
weight, pain in the worst knee visual analog scale (VAS), pain in other knee (yes/no), and pain,
Acoustic emission candidate biomarkers in knee OA
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function and stiffness scores using WOMAC. Data were recorded in a purpose-designed sheet,
together with the KL score for the X-ray of the worst knee.
MR imaging and segmentation
29 participants volunteered to also undergo MR imaging of the worst knee within 4 weeks of
AE and clinical assessment. MR images were acquired with a 3.0T Philips Achieva-X using a
Philips 16-element SENSE knee coil [10]. Sagittal fat-saturated MR images were acquired
using a Philips 3D WATSf sequence. Bone and cartilage were segmented by an experienced
manual segmenter, using a semi-automated livewire algorithm (Endpoint segmentation soft-
ware, Imorphics, Manchester, UK). Bone surfaces were automatically segmented using active
appearance models (AAMs), built from an independent training set. AAMs were applied to
the same 3D WATSf sequences [11]. Manual segmented bone surfaces were used for compari-
sons across the population. Cartilage thickness measures were taken using correspondence
points on bone surfaces (S1 Text, S2 Text).
Data analysis: Identifying initial candidate AE biomarkers
A developmental dataset comprising 8 participants was derived from the cohort. Of these, 5
had “clinically-mild” knee OA (KL score of 1 and mild or intermittent pain with little or no
functional impairment) whilst 3 had “clinically-severe” knee OA (KL score of 3 or 4 with sig-
nificant and persistent pain, and functional impairment). Initial candidate AE biomarkers
which segregated clearly with clinical severity within the developmental dataset were identi-
fied, of which 4 candidates were selected for detailed analysis using data from the remaining
cohort. Whilst one of the candidates was directly derived from the number of AE hits above
the 36 dB threshold setting of the machine, the other three candidates were derived based on
the methodology reported in [8]. It consisted of processing joint angle signals to divide each
sit-stand-sit movement into 4 quadrants, extracting average signal levels and peak signal
amplitudes from AE hits in each movement quadrant, forming the AE feature profile of each
knee in the developmental dataset based on two-dimensional histograms, and applying Princi-
pal Component Analysis (PCA) to yield the first three principal components as the three
candidates.
Data analysis: Evaluating initial candidate AE biomarkers
The 4 initial candidate biomarkers were evaluated with respect to reproducibility and their
associations with participant characteristics and disease specific markers. To assess variability
between patients, between machines, between RPs and between visits, and to account for vari-
ability introduced by the application of sensors, which is not necessarily a systematic difference
between RPs, 2 separate linear mixed effects models were fitted; a ‘day one’ model and a longi-
tudinal model. Both models included a fixed effect term for JAAS machines and random
effects terms to capture between-patient variability, between- RP variability and residual error.
The longitudinal model further included a random effect capturing day-to-day variability
whereas the ‘day one’ model included a random effect for between-session variability within a
day. A ’session’ is a time unit during which the sensors are not removed and re-applied. The
models were fitted separately for each of the candidate biomarkers. The models were devel-
oped using data from 45 participants who consented to take part in the repeated measure-
ments study.
To assess associations with other markers and patient characteristics, a linear mixed effects
model was fitted for each candidate biomarker. The model included fixed effects for covariates
of interest, a participant- specific random effect that accounts for correlation between repeated
Acoustic emission candidate biomarkers in knee OA
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measurements within the same individual, and a residual error term. A multiple regression
model was developed using forward selection based on the likelihood ratio test with a cut-off
for significance of p<0.1. The model was developed on 68 participants who had complete data
and the final model was refitted using data from 76 participants for whom complete data were
available on the covariates used in the final model. Data used in the developmental dataset
were excluded.
All analyses were performed using the statistical computing environment R and the ‘lme4’
package. Parameters in final models were estimated using restricted maximum likelihood.
Confidence intervals provided are based on the likelihood profile (S3 Text).
Ethics statement
The study was reviewed and approved by Health Research Authority National Research Ethics
Service Committee North West–Lancaster Research Ethics Committee reference 13/NW/
0732.
Written consent was gained by all participants and a signed copy held in the site file.
Results
Age, BMI and weight profiles of participants for whom complete data sets were available
(n = 68, comprising 36 males, 32 females) are shown in Fig 1, and WOMAC scores for Pain,
Stiffness and Function in this group are shown in Table 1.
Fig 2 shows the distribution of central femoral condyle and central medial tibia cartilage
thickness measurements among the 29 participants who underwent MRI studies.
Fig 1. Distribution of age, BMI and weight profiles of participants (n = 68) with complete datasets. Within this
group, 12 participants had a KL1 score, 22 had KL2, 27 had KL3 and 7 had KL4.
https://doi.org/10.1371/journal.pone.0223711.g001
Table 1. WOMAC score profile of participants (n = 68). The table shows median and IQR values for each domain
of Pain, Stiffness and Function.
WOMAC scores Median interquartile range
Pain 17 6–28
Stiffness 10 4–13
Function 61.5 16–90
https://doi.org/10.1371/journal.pone.0223711.t001
Acoustic emission candidate biomarkers in knee OA
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Acceptability and reproducibility of AE measurements
The protocol was feasible and acceptable to all participants and RPs. Although a few partici-
pants reported knee discomfort after the test, all were able to complete the protocol, and no
significant difficulties were observed or reported regarding symptoms or mobility. This is con-
sistent with our previous work, and supports the potential for using this technique in multi-
centre clinical trials.
Reproducibility was assessed in terms of within- session, day to day, week to week,
between-practitioner, and between- machine variation. Repeatability was good for all 4 candi-
dates when comparing the first and second sets of 5 movements within a session (Fig 3).
“Number of hits” showed strongest within-session repeatability, and the standard deviation
(SD) of measurements within the same session within the same patient was estimated to be
18.74—approximately half the SD of the “number of hits” measured in different sessions
(46.02) and a quarter of the SD of measurements taken on different participants (82.06;
Table 2, Part A). Table 2, Part B shows estimated contributions to variability for “number of
hits” from different sources in the longitudinal model. Variability between participants was
higher than variability due to day of measurement, RP and JAAS machine. However, the 3
PCA-based candidates showed relatively low levels of variability between participants, and also
suggested a possible effect of JAAS machine on the measurement.
Similar results were found in a concurrent study involving 73 other participants, with
machines calibrated at a narrower frequency range of 20 kHz to 80 kHz. Although the nar-
rower frequency range generated different AE outputs, it did not lead to differences in data
reproducibility or in relative contributions to measurement variability from the different fac-
tors investigated (S1 Table).
Fig 2. Distribution of cartilage thickness (n = 29). a) Thickness of cartilage on the central medial femoral condyle (anterior aspect) over total area of subchondral
bone representing subchondral bone area. Peripheral osteophytes are excluded, base of central osteophytes are included. b) Thickness of cartilage on the central medial
tibia over total area of subchondral bone representing premorbid subchondral bone area. Peripheral osteophytes are excluded, base of central osteophytes are included.
https://doi.org/10.1371/journal.pone.0223711.g002
Acoustic emission candidate biomarkers in knee OA
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These results show that differences between participants contributed the largest source of
variation in “number of hits”, supporting the rationale for focusing on “number of hits” mea-
surement for potential use in clinical trials.
Associations between initial candidate AE biomarkers and other markers
Whilst AE profiles in the worst knee differed from those in the contralateral knee for all 4 can-
didates, “number of hits” also showed significant associations with disease or other markers.
Therefore, for further analysis we focused only on “number of hits” for its potential as a candi-
date biomarker.
“Number of hits” was lower in knees with KL score 1 compared with KL score 2, but did
not distinguish between KL scores 2 and 3, or 3 and 4 (Fig 4, Table 3). The same result was
obtained in the analysis of the other dataset. However, there were qualitative differences
Fig 3. Within-session repeatability of each AE candidate biomarker. Each graph shows the biomarker value obtained from the first set of sit-stand-sit movements (x-
axis) plotted against the biomarker value obtained from the repeat set of movements (y-axis). Number of hits contained one outlier at (254, 873). This measurement was
omitted from the figure. S1 Fig shows the outlier included.
https://doi.org/10.1371/journal.pone.0223711.g003
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between the AE outputs from the two datasets (Fig 4). Although there was no clear trend in the
number of hits by KL score in our main study (see also S2 Table), a trend was apparent in the
other dataset. This raises the possibility that machine frequency settings may have a role in the
identification of further AE candidate biomarkers. Interestingly, whilst “number of hits” was
not associated with pain in the ipsilateral knee, it was significantly associated with pain in the
contralateral knee and with body weight (Table 3). S3 Table shows results from the univariable
analyses.
There was no evidence of significant relationships between “number of hits” and any of the
measures of cartilage thickness used in this study, involving either medial femoral central or
medial tibial central cartilage (S3 Table).
Analysis by movement quadrant
By dividing movements into 4 quadrants corresponding to different phases of ascending /
descending and accelerating / decelerating movement, we found that "number of hits" was
consistently higher in movement quadrants 1 and 4, corresponding to phases of “ascending-
acceleration” and “descending-deceleration” respectively, across all OA severity groups (Fig
5). Furthermore, the effect of "pain in the contralateral knee" on "number of hits" was strongest
in the descending-deceleration phase, suggesting that AE due to factors in the other knee may
also be quadrant-related.
Discussion
There is increasing interest in potential applications of AE in musculoskeletal and other clini-
cal conditions [12–22], and it has been demonstrated that AE is associated with experimental
cartilage damage in an in vitro equine model [23]. The recent development of techniques for
analysing AE extends previous concepts using vibration signals to inform diagnosis of knee
conditions [24]. For example, Lee et al [25] used vibration arthrometry to identify OA
Table 2. Variability profile for AE “number of hits”. Table 2: Part A: Point estimates and 95% confidence intervals for the standard deviations of the random effect
terms and the regression coefficients of the JAAS machine relative to JAAS 1 in the ‘day 1’ model of the ‘Number of hits’. (LCL: lower confidence limit; UCL: upper confi-
dence limit). Table 2: Part B: Point estimates and 95% confidence intervals for the standard deviations of the random effect terms and the regression coefficients of the
JAAS machine relative to JAAS 1 in the longitudinal model of the ‘Number of hits’. (LCL: lower confidence limit; UCL: upper confidence limit).
Parameter Model without covariate adjustment Model with covariate
adjustment
Point Estimate 95% LCL 95% UCL Point Estimate 95% LCL 95% UCL
A
Session in patient variability 46.02 38.84 55.12 46.56 39.25 55.81
Patient variability 82.06 62.65 101.12 79.11 51.96 86.62
RP variability 6.05 0.00 22.65 5.77 0.00 22.50
Residual variability 18.74 16.60 21.37 18.58 16.44 21.22
JAAS 2 20.39 -36.87 77.61 19.57 -36.70 75.97
JAAS 3 -66.38 -137.07 4.17 -52.83 -126.68 21.03
B
Day in patient
variability
55.75 49.71 62.93 55.98 49.47 63.39
Patient variability 79.15 60.55 101.40 74.49 48.04 87.16
RP variability 47.22 0.00 87.92 47.72 0.00 94.14
Residual variability 19.42 17.63 21.54 19.85 17.95 22.11
JAAS 2 1.16 -68.49 67.53 1.33 -68.37 69.58
JAAS 3 -26.77 -117.85 59.25 -4.08 -113.57 99.76
https://doi.org/10.1371/journal.pone.0223711.t002
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subgroups among 36 people with patella femoral crepitus, based on location of cartilage dam-
age, whilst Krishnan et al [26] investigated vibroarthrography in diagnosing chondromalacia
patellae by studying 39 people with knee conditions and 51 people with normal knees. How-
ever, although vibroarthrography and AE share some similarities conceptually, the principles
and protocols involved differ markedly. In particular, our AE technique focuses on capture
and analysis of high frequency acoustic signals (20 to 400 kHz) emitted from knees during
weight bearing movement. We have developed a convenient, non-invasive and portable system
to capture and analyse high-frequency sound emitted during weight-bearing knee movement
[4–9] and are focusing on AE as a marker of knee OA severity, rather than as a diagnostic tool.
AE reflects aspects of joint function to which conventional imaging and soluble biomarkers
are insensitive. It reflects dynamic interaction among joint components as a result of move-
ment, and complements traditional imaging biomarkers which reflect static anatomy. Unlike
many existing clinical measures, AE offers an objective and quantitative measurement tool,
which can be standardized across centres and patients.
Fig 4. Relationship between AE number of hits and KL score. Fig 4 left panel shows the relationship between AE
number of hits and KL score for the main study group. Fig 4 right panel shows the relationship between AE number of
hits and KL score for the concurrent study group (n = 73) for which data were collected using a frequency range of 20
kHz—80 kHz.
https://doi.org/10.1371/journal.pone.0223711.g004
Table 3. Parameter estimates in multiple regression model for AE number of hits. Point estimates and 95% confi-
dence intervals for parameter estimates in the multiple regression model for the ‘Number of hits’. (LCL: lower confi-
dence limit; UCL: upper confidence limit). The intercept is the average number of hits across all KL scores in
individuals of mean weight and no pain in the contralateral knee.
Parameter Point Estimate 95% LCL 95% UCL
Intercept 160.13 124.67 195.6
KL 1 vs KL 2 -81.77 -143.41 -20.13
KL 2 vs KL 3 22.54 -25.87 70.95
KL 3 vs KL 4 38.39 -33 109.78
Weight 2.06 0.76 3.37
Pain in contralateral knee 57.05 14.13 99.97
Standard deviation of participant specific random effect 93.17 76.58 105.98
Standard deviation of residual error 22.51 19.39 26.57
https://doi.org/10.1371/journal.pone.0223711.t003
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In this study we investigated whether AE measurements can be used to identify novel can-
didate biomarkers for potential use in clinical trials and stratified medicine applications. Given
the heterogeneity of knee OA, the availability of biomarkers to enable better definition of
patient subgroups and better, more objective assessment of the outcome of interventions
would support the design of multicenter clinical trials for this condition. Our aim was to deter-
mine the efficacy and feasibility of a new approach for identifying candidate biomarkers for
knee OA, based on a strategy of selecting promising candidates from a range of acoustic emis-
sion (AE) measurements generated during weight-bearing knee movement. Our rationale was
that if it proved possible to identify candidate biomarkers by screening AE data generated
using a defined knee movement protocol, such candidates could then be further tested and val-
idated in larger scale studies. Furthermore, the same principles and approach could be used in
future studies to generate further candidates, perhaps opening the way for characterising
patient subgroups, and enabling stratified medicine approaches to be explored for knee OA. In
this initial study we focused in particular on the acceptability and reproducibility of an initial
set of selected AE candidate biomarkers, and on their associations with other knee OA mark-
ers. This study is the first to investigate AE in a large population cohort with previously-diag-
nosed knee OA, and also the first to address systematically the reproducibility of AE
measurement. Although this field is as yet at an early stage, our findings demonstrate the
potential for using this approach in biomarker generation and clinical trials, as well as identify-
ing areas for further technical development and improvement.
Participants with a range of knee OA severity were measured by trained RPs in primary
care and secondary care settings. Use of the equipment or the protocol caused no significant
problems necessitating discontinuation of the test. We anticipated that the protocol might
prove challenging for some participants to complete (S2 Fig) but this proved not to be the case
Furthermore, none of the RPs reported significant practical difficulties in using the JAAS,
although a rigorous training programme and access to technical advice throughout data collec-
tion were key factors in ensuring acceptability of the technique.
We initially identified 4 candidate AE biomarkers for detailed analysis. Of these, “number
of hits” showed strongest potential for further development as a candidate biomarker. The
Fig 5. Relationship between AE number of hits and movement quadrant. The distribution of AE number of hits by
each movement quadrant is shown for participants with KL scores of 1 and KL scores of 2 or higher.
https://doi.org/10.1371/journal.pone.0223711.g005
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“number of hits” measurement showed higher levels of inter-participant variability compared
to other sources of variability, and there was a difference on average in “number of hits”
between knees scoring KL1 or KL 2. The same results were obtained from another dataset col-
lected using the same equipment and protocol but with a narrower frequency range. This data-
set showed a trend of increasing number of hits with increasing KL score. Although
differences between KL2 and KL3, and KL3 and KL4 were not statistically significant, this sug-
gests that machine frequency settings may have a role to play in the further development of AE
biomarkers. No associations were found between “number of hits” and any other markers
tested, including femoral and tibial cartilage thickness, or pain severity in the ipsilateral knee.
Arguably, potentially useful new knee OA biomarkers would not show positive associations
with current measures of severity, given that these have very limited utility. Our findings that
“number of hits” showed good intra- and inter-session reproducibility and differed on average
between KL1 and KL2 suggest that this measurement may have potential applications in popu-
lation-based cohort studies and clinical trials by measuring aspects not captured by currently-
available measures.
“Number of hits” was consistently higher in movement quadrants 1 and 4 across the range
of knee OA severity, suggesting that these phases within ascending and descending movements
may be particularly informative, not only for clinical measurement but also for investigating
origins for acoustic signals. Furthermore, whilst different quadrants are not distinguished by
discrete cut-off points, it is notable that quadrants 1 and 4 correspond closely to movement
phases which have been found, using instrumented knee implants, to generate the highest
average loading resultant forces within knees [27]. Whilst the physical and clinical characteris-
tics of that study group may not be analogous to ours, these findings nevertheless raise the pos-
sibility that “number of hits” may be related to joint loading forces generated during specific
phases of standing and sitting movements.
Our finding that “number of hits” differs on average between KL1 and KL 2 but is also
influenced by body weight and by pain in the contralateral knee suggests that AE may provide
a composite readout, determined by structural change together with factors relevant to joint
loading. The association of “number of hits” with both body weight and contralateral knee
pain might be linked to altered biomechanics during sit-stand-sit movements. It has been
reported that whilst people of normal weight produce hip torques which are higher than knee
torques during sit-stand-sit movements, strategies used by obese people produce knee torques
which are higher than hip torques [28]. Potentially, this may lead to higher “number of hits” in
knees of obese people during sit-stand-sit movements. Furthermore, people with advanced
knee OA transmit up to 10% more load through their contralateral leg during sit-stand-sit
movements [29, 30]. Increased loading in the contralateral limb during gait has also been doc-
umented, and an association with subsequent development of damage in contralateral joints
has been suggested [31–34]. Biomechanical changes in gait offer a possible rationale for
explaining associations not only between “number of hits” and severity of knee OA as reflected
by KL scores, but also between “number of hits” and contralateral knee pain, since higher load-
ing through the contralateral leg due to knee OA may be responsible for contralateral knee
pain. Future work to measure simultaneously “number of hits” and joint loading in knees dur-
ing sit-stand-sit movements may provide a better understanding of the mechanisms involved,
whilst deeper analysis of AE data according to defined localized anatomical features, or by
identifying the most strongly repeatable AE waveform features, may reveal acoustic waveforms
characteristic of specific features of joint condition.
Further modification of methods and materials for sensor attachment may reduce variance
between sessions, for example by improving standardisation of sensor attachment, or improv-
ing consistency in sensor anatomical location. Reduction of between-session variance would
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reduce numbers of measurements needed while maintaining scientific value and user conve-
nience of the method. This would support further the rationale for including AE measurement
in knee OA clinical trials. For drug development, in both Europe [35] and United States [36],
regulators will consider claims for slowing or prevention of structural damage. EMA notes
that to assess effects of structure-modifying drugs, it may be advantageous to select patients at
high risk for progression. Both FDA and EMA note that neither MRI nor radiography are
ideal for evaluating OA severity, and recognise the need to develop alternative technologies.
Since AE merits further investigation as one such technology, we have modelled a power calcu-
lation for a notional clinical trial of an intervention for knee OA which measured “number of
hits” as one of its outcomes. Based on findings of the study reported here, a phase 2 clinical
trial in people with KL scores of 2 or more would require approximately 400 participants per
group to provide the trial with 80% power to demonstrate a 50% reduction in “number of
hits”. Whilst such calculations are notional currently, and the clinical significance of such
changes requires further investigation, they nevertheless indicate the feasibility of designing
clinical trials along these lines.
In summary, measurement of AE number of hits using a simple sit-stand-sit movement
protocol offers a novel and convenient approach for assessing the integrity of interactions
between joint components during weight bearing movement. The results of this study demon-
strate the potential for this method to enable the identification of new candidate biomarkers,
prior to their subsequent validation in large-scale studies and future applications in multicen-
tre clinical trials of knee OA. Whilst the key determinants of acoustic signals are yet to be eluci-
dated, current work exploring associations between specific AE waveform features and
defined structural features may help provide insights into this important issue. Future work
will determine whether AE measurements should focus on specific movement phases, refine
the equipment to enhance its usability in clinic settings and assess the role of frequency ranges
used to capture AE signals.
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